Top 2 Health Care Stocks You May Want To Dump This Quarter – Medpace Hldgs (NASDAQ:MEDP), Recursion Pharmaceuticals (NASDAQ:RXRX)

Since July 22, 2025, 2 stocks in the healthcare sector might be flashing a genuine caution to financiers who value momentum as a crucial requirements in their trading choices.

The RSI is a momentum sign, which compares a stock’s strength on days when rates increase to its strength on days when rates decrease. When compared to a stock’s rate action, it can provide traders a much better sense of how a stock might carry out in the short-term. A property is generally thought about overbought when the RSI is above 70, according to Benzinga Pro.

Here’s the current list of significant overbought gamers in this sector.

Medpace Holdings Inc MEDP

• On July 21, Medpace Holdings reported better-than-expected second-quarter monetary outcomes and raised its FY25 assistance above price quotes. Medpace anticipates 2025 earnings to be in the variety of $2.42 billion to $2.52 billion, up from previous assistance of $2.14 billion to $2.24 billion. The business likewise raised its full-year profits assistance from a variety of $12.26 to $13.04 per share versus price quotes of $13.76 to $14.53 per share. Experts are anticipating 2025 earnings of $2.18 billion and profits of $12.69 per share. The business’s stock leapt around 192% over the previous 5 years and has a 52-week high of $440.38.
• RSI Worth: 83.2
• MEDP Cost Action: Shares of Medpace fell 1% to close at $308.88 on Monday.
• Edge Stock Rankings: 19.90 Momentum rating with Worth at 23.62.

Recursion Pharmaceuticals Inc RXRX

• On July 8, Recursion Pharmaceuticals revealed it obtained the joint ENPP1 inhibitor program and associated backup particle from Rallybio. “We extend our genuine thanks to Rallybio for their important collaboration beforehand this program to its existing phase,” stated David Hallett, Chief Scientific Officer of Recursion. The business’s stock got around 33% over the previous month has a 52-week high of $12.36.
• RSI Worth: 75.6
• RXRX Cost Action: Shares of Recursion Pharmaceuticals got 9.6% to close at $6.40 on Monday.

Curious about other BZ Edge Rankings? Click on this link to find how comparable stocks determine up.

Read This Next:

Picture by means of Shutterstock